{"title":"Demographics and lifestyle factors of patients with hidradenitis suppurativa: An All of Us database analysis","authors":"Gaurav N. Pathak PharmD , Timothy Makkar MD , Suraj S. Pathak BS , Shazli Razi MD , Cindy Wassef MD , Babar Rao MD","doi":"10.1016/j.jdin.2024.08.002","DOIUrl":"10.1016/j.jdin.2024.08.002","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"17 ","pages":"Pages 67-70"},"PeriodicalIF":0.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-02DOI: 10.1016/j.jdin.2024.08.006
Yuki M.F. Andersen MD, PhD , Johan Sieborg MSc , Lea Nymand MSc , Tiago Torres MD, PhD , Andrea Chiricozzi MD , Simon Francis Thomsen MD, PhD, DMSc , Jacob P. Thyssen MD, PhD, DMSc , Alexander Egeberg MD, PhD, DMSc
Background
Oral Janus kinase inhibitors (JAKis) have black-box warnings of infections, cancer risk, and cardiovascular and venous thromboembolic events. They may be used off-label for chronic hand eczema (CHE).
Objectives
Assess the prevalence of risk factors potentially impacting oral JAKi safety in CHE patients.
Methods
In the Danish Skin Cohort, CHE patients were examined for risk factors affecting oral JAKi use at baseline and followed for 12 months. Data were collected through register linkage (eg, cancer history) and through patient interviews (eg, smoking habits).
Results
Of 941 adults with CHE (66.2% women; mean age 55.5 [SD 13.3] years), 768 (81.6%) patients had at least one risk factor potentially impacting oral JAKi use, of which 682 (72.5%) had nonmodifiable risk factors. Most common risk factors were current or former heavy smoking (62.8%, n = 591), obesity (28.1%, n = 264), hypercholesterolemia (21.5%, n = 202), and hypertension (18.8%, n = 177). Among patients without any risk factors at baseline (n = 173), 20.2% (n = 35) developed ≥1 risk factor during the following 12 months.
Limitations
Certain risk factors may be underreported.
Conclusion
Most CHE patients have risk factors limiting appropriateness of oral JAKi use. Health care providers should assess risk factors in their patients when choosing treatment for CHE.
{"title":"Risk factors that limit use of oral JAK inhibitors in chronic hand eczema: Findings from the Danish Skin Cohort","authors":"Yuki M.F. Andersen MD, PhD , Johan Sieborg MSc , Lea Nymand MSc , Tiago Torres MD, PhD , Andrea Chiricozzi MD , Simon Francis Thomsen MD, PhD, DMSc , Jacob P. Thyssen MD, PhD, DMSc , Alexander Egeberg MD, PhD, DMSc","doi":"10.1016/j.jdin.2024.08.006","DOIUrl":"10.1016/j.jdin.2024.08.006","url":null,"abstract":"<div><h3>Background</h3><div>Oral Janus kinase inhibitors (JAKis) have black-box warnings of infections, cancer risk, and cardiovascular and venous thromboembolic events. They may be used off-label for chronic hand eczema (CHE).</div></div><div><h3>Objectives</h3><div>Assess the prevalence of risk factors potentially impacting oral JAKi safety in CHE patients.</div></div><div><h3>Methods</h3><div>In the Danish Skin Cohort, CHE patients were examined for risk factors affecting oral JAKi use at baseline and followed for 12 months. Data were collected through register linkage (eg, cancer history) and through patient interviews (eg, smoking habits).</div></div><div><h3>Results</h3><div>Of 941 adults with CHE (66.2% women; mean age 55.5 [SD 13.3] years), 768 (81.6%) patients had at least one risk factor potentially impacting oral JAKi use, of which 682 (72.5%) had nonmodifiable risk factors. Most common risk factors were current or former heavy smoking (62.8%, <em>n</em> = 591), obesity (28.1%, <em>n</em> = 264), hypercholesterolemia (21.5%, <em>n</em> = 202), and hypertension (18.8%, <em>n</em> = 177). Among patients without any risk factors at baseline (<em>n</em> = 173), 20.2% (<em>n</em> = 35) developed ≥1 risk factor during the following 12 months.</div></div><div><h3>Limitations</h3><div>Certain risk factors may be underreported.</div></div><div><h3>Conclusion</h3><div>Most CHE patients have risk factors limiting appropriateness of oral JAKi use. Health care providers should assess risk factors in their patients when choosing treatment for CHE.</div></div>","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"17 ","pages":"Pages 61-66"},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-02DOI: 10.1016/j.jdin.2024.08.003
Vraj K. Shah BS , Rajiv I. Nijhawan MD
{"title":"Risk of multiple primary cancers in patients with atypical fibroxanthoma/pleomorphic dermal sarcoma: A SEER analysis","authors":"Vraj K. Shah BS , Rajiv I. Nijhawan MD","doi":"10.1016/j.jdin.2024.08.003","DOIUrl":"10.1016/j.jdin.2024.08.003","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"17 ","pages":"Pages 51-52"},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01DOI: 10.1016/j.jdin.2024.07.027
Eddy M. Zitha MSc, MD , Ogheneochuko U. Oputu PhD , Sthomo Mevana ND, BTECH , Bukiwe Thwala MPH , Lovemore Mapahla MSc , Aneliswa Mpungose BCMP , Thuraya Isaacs MD, MFamMed, MMed , Jonny Peter MD, PhD , Rannakoe J. Lehloenya BSc, MD , Nonhlanhla P. Khumalo MD, PhD
{"title":"Patients with severe cutaneous adverse drug reactions have extremely high hair cortisol concentrations that do not correlate with the presence of depression","authors":"Eddy M. Zitha MSc, MD , Ogheneochuko U. Oputu PhD , Sthomo Mevana ND, BTECH , Bukiwe Thwala MPH , Lovemore Mapahla MSc , Aneliswa Mpungose BCMP , Thuraya Isaacs MD, MFamMed, MMed , Jonny Peter MD, PhD , Rannakoe J. Lehloenya BSc, MD , Nonhlanhla P. Khumalo MD, PhD","doi":"10.1016/j.jdin.2024.07.027","DOIUrl":"10.1016/j.jdin.2024.07.027","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"17 ","pages":"Pages 163-166"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142528969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-01DOI: 10.1016/j.jdin.2024.08.005
Jeffrey N. Li MD, Ryan J. Scheinkman MEng, Brian W. Morrison MD
{"title":"Biopsy-proven diagnoses associated with monodactylous longitudinal nail plate change in a diverse patient population: A retrospective cross-sectional study","authors":"Jeffrey N. Li MD, Ryan J. Scheinkman MEng, Brian W. Morrison MD","doi":"10.1016/j.jdin.2024.08.005","DOIUrl":"10.1016/j.jdin.2024.08.005","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"17 ","pages":"Pages 58-60"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-31DOI: 10.1016/j.jdin.2024.07.025
Lillian McCampbell BS , David Jun Fei-Zhang BA , Daniel Chelius MD , Ling-Lun Bob Hsia MD , Jeffrey Rastatter MD , Anthony Sheyn MD
{"title":"Social vulnerability and outcomes of head and neck cutaneous squamous cell carcinoma: A retrospective cohort study","authors":"Lillian McCampbell BS , David Jun Fei-Zhang BA , Daniel Chelius MD , Ling-Lun Bob Hsia MD , Jeffrey Rastatter MD , Anthony Sheyn MD","doi":"10.1016/j.jdin.2024.07.025","DOIUrl":"10.1016/j.jdin.2024.07.025","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"17 ","pages":"Pages 48-50"},"PeriodicalIF":0.0,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-31DOI: 10.1016/j.jdin.2024.07.026
Dominique Mosley BS, MD , Christopher Madden BS , Jacqueline Ike MHS , Isabelle T. Smith , Sarah Grossarth MPH , Lee Wheless MD, PhD
{"title":"Human leukocyte antigen type does not improve risk stratification for SUNTRAC score in solid organ transplant recipients: A cohort study","authors":"Dominique Mosley BS, MD , Christopher Madden BS , Jacqueline Ike MHS , Isabelle T. Smith , Sarah Grossarth MPH , Lee Wheless MD, PhD","doi":"10.1016/j.jdin.2024.07.026","DOIUrl":"10.1016/j.jdin.2024.07.026","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"17 ","pages":"Pages 80-81"},"PeriodicalIF":0.0,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142415956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-27DOI: 10.1016/j.jdin.2024.07.023
Ambika Nohria BA , Deesha Desai BS , Michelle Sikora BS , Nnaemeka Anyanwu BA , Avrom Caplan MD , Jerry Shapiro MD , Kristen Lo Sicco MD
{"title":"Improving efficacy and maintaining safety in the treatment of alopecia with low-dose oral minoxidil and spironolactone combination therapy: A retrospective review","authors":"Ambika Nohria BA , Deesha Desai BS , Michelle Sikora BS , Nnaemeka Anyanwu BA , Avrom Caplan MD , Jerry Shapiro MD , Kristen Lo Sicco MD","doi":"10.1016/j.jdin.2024.07.023","DOIUrl":"10.1016/j.jdin.2024.07.023","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"17 ","pages":"Pages 24-26"},"PeriodicalIF":0.0,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}